Risk assessment in patients with functional class II pulmonary arterial hypertension: Comparison of physician gestalt with ESC/ERS and the REVEAL 2.0 risk score.
<h4>Background</h4>Accurate and regular risk assessment is important for evaluation and treatment of pulmonary arterial hypertension (PAH) patients, including those with functional class (FC) II symptoms, a population considered at low risk for disease progression. Risk assessment method...
Main Authors: | Sandeep Sahay, Adriano R Tonelli, Mona Selej, Zachary Watson, Raymond L Benza |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0241504 |
Similar Items
-
The effect of hypoxia on ER-β expression in the lung and cultured pulmonary artery endothelial cells
by: Selej, Mona M.A.
Published: (2014) -
2015 ESC/ERS GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF PULMONARY HYPERTENSION
by: Nazzareno Galiè, et al.
Published: (2016-05-01) -
2009 ESC/ERS Pulmonary Hypertension Guidelines and Connective Tissue Disease
by: Norifumi Nakanishi
Published: (2011-01-01) -
Theologie und Vergangenheitsbewältigung VI. Diskurse über „Form“, „Gestalt“ und „Stil“ in den 20er und 30er Jahren
by: Julia Albert, Timo Bayer, Lisa Busche, Alexander Haser, Katharina Peetz
Published: (2015-04-01) -
Real-world experience using combination therapy with riociguat and risk assessment using REVEAL Lite 2.0 in patients with pulmonary arterial hypertension
by: Sandeep Sahay, et al.
Published: (2020-02-01)